Short answer
Pennant Group, Inc. (PNTG) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $298M (up 35.8% year over year) with net income of $9M.
Q2 2026 key financials · XBRL
- Revenue
- $298M
- +35.8% YoY · +4.4% QoQ
- Net income
- $9M
- +28.2% YoY · +6.6% QoQ
- Operating margin
- 5.8%
- EPS (diluted)
- $0.25
- +25.0% YoY · +4.2% QoQ
Source: XBRL data from the Pennant Group, Inc. (PNTG) Q2 2026 10-Q on SEC EDGAR. USD.
Pennant Group, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New risk: AI adoption creates healthcare regulatory, privacy, and business risks
- Regulatory risk: Evolving AI laws may increase compliance costs or restrict current practices
- Compliance risk: AI errors could trigger patient-care claims, enforcement, and reputational harm
- Operational risk: Inaccurate or biased AI outputs could affect clinical and administrative decisions
- Competitive risk: More effective competitor AI deployment could weaken Pennant’s market position
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Pennant Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.